PHARMATHEN
LIVE

Serial Number

86855211

Owner

Pharmathen S.A.

Attorney

Bradford C. Craig

Filing Date

Dec 21, 2015

Add to watchlist:

No watchlists yet
View on USPTO

PHARMATHEN Trademark

Serial Number: 86855211 • Registration: 5174238

PHARMATHEN is a trademark filed by Pharmathen S.A. on December 21, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Pharmathen S.A. (4 trademarks)

6 Dervenakion Street
Pallini Attikis GR-15351 , GR

Entity Type: 03

Trademark Details

Filing Date

December 21, 2015

Registration Date

April 4, 2017

Published for Opposition

January 17, 2017

Goods & Services

Medical and scientific research services in the field of cancer treatment and diagnosis; Generic pharmaceutical drug development services; generic Pharmaceutical research services; Professional consulting services and advice about agricultural chemistry; Scientific consulting and research services relating to foods and dietary supplements; Technical consultancy in relation to research services relating to foods and dietary supplements; Scientific investigations for medical purposes in the field of generic pharmaceuticals; Scientific research in the field of generic pharmaceuticals; Scientific research and development in the field of generic pharmaceuticals

Generic pharmaceutical preparation for the treatment of gout; Generic pharmaceutical preparations acting on the central nervous system; Generic pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Generic pharmaceutical preparations for animal skincare; Generic pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Generic pharmaceutical preparations for ocular or intraocular surgery; Generic pharmaceutical preparations for the treatment of heart rhythm disorders; Generic pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Generic pharmaceutical preparations for the treatment of infectious diseases; Generic pharmaceutical preparations for treating allergic rhinitis and asthma; Generic pharmaceutical preparations for treating diabetes; Generic pharmaceutical preparations for treating skin disorders; Generic pharmaceutical preparations for use in chemotherapy; Generic pharmaceutical preparations for use in dermatology; Generic pharmaceutical preparations for use in urology; Generic pharmaceutical preparations for wounds; Generic pharmaceutical preparations, namely, anticoagulants; Generic pharmaceutical preparations, namely, antidepressants; Generic pharmaceutical preparations, namely, appetite suppressants. Generic pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Generic pharmaceutical preparations, namely, a drug delivery system comprising polymerbased oral tablets for the continuous release of a wide variety of therapeutic agents; Preparations for destroying parasites; Preparations for destroying vermin; Sanitary preparations for medical use; Self adhesive dressings; Veterinary preparations, namely, pain relief medication

Providing advertising, marketing and promotional services for the generic pharmaceutical and medical industry. Providing advertising, marketing and promotional services for the generic pharmaceuticals and medical products of others; Providing information on the topic of promoting patient, physician and employee satisfaction via a global computer network

Education services, namely, mentoring in the field of generic pharmaceuticals, diagnostic preparations, veterinary preparations, proprietary medicines, toiletries and cosmetics; Educational services, namely, providing classes, seminars and workshops in the fields of generic pharmaceuticals, diagnostic preparations, veterinary preparations, proprietary medicines, toiletries and cosmetic industries; Providing continuing medical education courses

Medical services; Providing health care information by telephone; Providing health care information by telephone and the Internet; Providing health information; Providing information about beauty; Providing medical information, consultancy and advisory services in the field of generic pharmaceuticals; Veterinary services

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 4, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 19, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 19, 2024 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 22, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 22, 2023 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 22, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 22, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 4, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 4, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 17, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 17, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 28, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 13, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2016 CRFA
ASSIGNED TO LIE
Nov 10, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 28, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jul 26, 2016 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2016 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2015 NWOS
NEW APPLICATION ENTERED
Dec 28, 2015 NWAP